NEW YORK (GenomeWeb News) – Bio-Rad Laboratories said today that it will raise $300 million through the sale of senior notes through a private offering.

The $300 million, which the company plans to use for general corporate purposes, working capital, and potentially for acquisitions, is an increase of $50 million over what the company said on Monday that it planned to receive from the sale.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Publication of He Jiankui's work on gene-edited infants would raise ethical concerns for journals, Wired and others report.

The New York Times reports that evidence linking trauma in one generation to epigenetic effects that influence subsequent generations may be overstated.

ScienceInsider reports that US National Institutes of Health researchers were told in the fall they could not obtain new human fetal tissue.

In PNAS this week: skin pigmentation evolution among KhoeSan, biomarkers for dengue virus progression, and more.